Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT07105033
- Status
- Recruiting
Conditions
- Advanced Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- FACT Session — BEHAVIORALParticipants will participate in 4 weekly, 35-45 minute sessions
- Enhanced Usual Care and Assessments — BEHAVIORALParticipants will complete a symptoms questionnaire
Study Details
To learn about the effects of an intervention program called Focused Acceptance and Commitment Therapy (FACT) on the level of anxiety patients diagnosed with cancer feel about death. To learn if an intervention program called Focused Acceptance and Commitment Therapy (FACT), designed to help reduce death-related anxiety, is effective and acceptable to patients diagnosed with advanced cancer.
Key Dates
- Start date
- Jul 21, 2025
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Examine Initial Acceptability and Efficacy Signal of FACTPotential participants will be identified weekly via MDACC's computerized appointment system for the Supportive Care Outpatient Clinic.
- Experimental: Controlled Trial (RCT) to Examine Feasibility, Acceptability and Initially Efficacy of FACTPotential participants will be identified weekly via MDACC's computerized appointment system for the Supportive Care Outpatient Clinic.
Primary Outcome Measure
1. Safety and Adverse Events (AEs) [ Time Frame: Through study completion; an average of 1 year ]
Central Contacts
- Juliet Kroll, BA,PHD(346) 723-5858
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas M. D. Anderson Cancer Center | Houston | Texas | 77030 | Juliet Kroll, BA,PHD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Psychophysical Studies of Cancer Therapy PainRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · Artios Pharma Ltd · Birmingham, Alabama
- Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsPHASE1 · Recruiting · I-Mab Biopharma US Limited · Orange, California
- Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid TumorsPHASE1 · Recruiting · Riboscience, LLC. · Scottsdale, Arizona